World's Best Scientists 2026 revealed!
Expert Opinion on Biological Therapy
H-index 37

Expert Opinion on Biological Therapy

1471-2598

Published by: Taylor & Francis

https://www.tandfonline.com/toc/iebt20/current

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 619 168 211 31

Additional Metrics

Number of Best Scientists*: 276
Documents by Best Scientists*: 295
Top 100 Ranked Scientists*: 12
SCIMAGO H-index: 107
SCIMAGO SJR: 1.15
Impact Factor: 4

Overview

Top Research Topics at Expert Opinion on Biological Therapy?

Immunology, Internal medicine, Immunotherapy, Oncology and Clinical trial are among the topics commonly tackled in the journal. It dives deep in exploring the relationship between the study of Immunology and Disease. Chemotherapy are all disciplines of Internal medicine that connect with topics in In patient.

T cell and Cancer research are some topics wherein Immunotherapy research discussed in it have an impact. Expert Opinion on Biological Therapy focuses on Cancer research research which is adjacent to topics in Genetic enhancement. Clinical trial studies covered in Expert Opinion on Biological Therapy falls within the purview of Bioinformatics.

While the journal focused on Immune system, it was also able to explore topics like Vaccination and Virology.

  • Immunology (40.18%)
  • Internal medicine (22.53%)
  • Immunotherapy (14.22%)

What are the most cited papers published in the journal?

  • HSP90 as a new therapeutic target for cancer therapy: the story unfolds. (483 citations)
  • MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. (352 citations)
  • Venoms as a platform for human drugs: translating toxins into therapeutics (344 citations)

Research areas of the most cited articles at Expert Opinion on Biological Therapy:

The most cited articles tackle a plethora of topics, such as Immunology, Immune system, Cancer, Immunotherapy and Internal medicine. The published papers explore issues in Immunology which can be linked to other research areas like Cancer research, Clinical trial and Mesenchymal stem cell. While the published articles focused on Internal medicine, they were also able to explore topics like Endocrinology, Oncology and Pharmacology.

What topics the last edition of the journal is best known for?

  • Internal medicine
  • Cancer
  • Disease

The previous edition focused in particular on these issues:

The journal mainly tackles studies in Cancer research, Internal medicine, Biosimilar, Cancer and Immunotherapy. Cancer research research in it involves the investigation of Antibody studies, all of which are linked to disciplines such as Drug and Targeted therapy. Expert Opinion on Biological Therapy explores topics in Internal medicine which can be helpful for research in disciplines like Psoriasis and Oncology.

The studies on Cancer discussed can also contribute to research in the domains of Blockade and Bioinformatics. Expert Opinion on Biological Therapy explores research in Intensive care medicine and overlapping concepts in Omalizumab to expand the discourse in Clinical trial. The study on Disease presented is investigated in conjunction with research in Immunology.

The most cited articles from the last journal are:

  • Characteristic of Chronic Plaque Psoriasis Patients Treated with Biologics in Italy during the COVID-19 Pandemic: Risk Analysis from the PSO-BIO-COVID Observational Study (14 citations)
  • Small extracellular vesicles (sEVs): discovery, functions, applications, detection methods and various engineered forms. (12 citations)
  • Brexucabtagene autoleucel for the treatment of relapsed/refractory mantle cell lymphoma (10 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Expert Opinion on Biological Therapy (based on the number of publications) are:

  • Massimo Martino (16 papers) published 2 papers at the last edition,
  • Daniele Santini (14 papers) absent at the last edition,
  • Enrico Garaci (14 papers) absent at the last edition,
  • Michael A. Morse (14 papers) absent at the last edition,
  • Marco Galluzzo (13 papers) published 6 papers at the last edition, 2 more than at the previous edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Expert Opinion on Biological Therapy (based on the number of publications) are:

  • National Institutes of Health (53 papers) absent at the last edition,
  • University of Pittsburgh (43 papers) published 2 papers at the last edition, 1 more than at the previous edition,
  • University of Milan (39 papers) published 7 papers at the last edition the same number as at the previous edition,
  • University of Rome Tor Vergata (37 papers) published 8 papers at the last edition, 1 less than at the previous edition,
  • Harvard University (36 papers) published 3 papers at the last edition, 2 more than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 9.50% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 12.96% were posted by at least one author from the top 10 institutions publishing in the journal. Another 6.17% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 19.14% of all publications and 61.73% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Career Opportunities in Biological Therapy

The dynamic nature of research topics in Expert Opinion of Biological Therapy opens the road to a broad range of career opportunities. For instance, a professional specialized in Immunotherapy or Cancer Research will find it rewarding to contribute to the pressing issues being tackled by this journal. With a solid background in the major disciplines covered by the Expert Opinion on Biological Therapy, such a professional can venture into roles such as Immuno-Oncologist, Clinical Researcher, Bioinformatics Analyst, and not just limiting to a Nursing profession. There is a growing demand in West Virginia for nursing professionals with a deep understanding of these research topics. These registered nurses play a crucial role in providing patient care, educating patients about their conditions, and administering treatments. For those seeking to join this thriving medical profession in West Virginia, here is a comprehensive guide on how to become a registered nurse in West Virginia. This resource provides step by step guidance, right from prerequisites to the process of acquiring the necessary certifications. Embracing these career paths not only assists in honing professional skills but also contributes to progressing biomedical research as evidenced by the articles published in Expert Opinion on Biological Therapy. Hence, embarking on a career path in these fields can create a significant impact on the ongoing research on diseases and their treatment methodologies.

Top Publications

  • Platelet-rich plasma for the treatment of knee osteoarthritis: an expert opinion and proposal for a novel classification and coding system.

    Elizaveta Kon;Berardo Di Matteo;Berardo Di Matteo;Diego Delgado;Brian J Cole

    (2020)
    166 Citations
  • Addressing high dose AAV toxicity – ‘one and done’ or ‘slower and lower’?

    (2022)
    157 Citations
  • Mesothelin-targeted CAR-T cell therapy for solid tumors.

    Astero Klampatsa;Vivian Dimou;Steven M Albelda

    (2021)
    93 Citations
  • Modern use of 5-aminosalicylic acid compounds for ulcerative colitis

    Catherine Le Berre;Giulia Roda;Marijana Nedeljkovic Protic;Silvio Danese

    (2020)
    90 Citations
  • Sacituzumab govitecan, a novel, third-generation, antibody-drug conjugate (ADC) for cancer therapy.

    David M. Goldenberg;Robert M. Sharkey

    (2020)
    83 Citations
  • Role of Inducible Co-Stimulator (ICOS) in cancer immunotherapy.

    Florent Amatore;Laurent Gorvel;Daniel Olive

    (2020)
    80 Citations
  • Recent developments of RNA-based vaccines in cancer immunotherapy

    Elnaz Faghfuri;Farhad Pourfarzi;Amir Hossein Faghfouri;Mahdi Abdoli Shadbad

    (2021)
    70 Citations
  • Core decompression isolated or combined with bone marrow-derived cell therapies for femoral head osteonecrosis.

    Filippo Migliorini;Nicola Maffulli;Nicola Maffulli;Nicola Maffulli;Jörg Eschweiler;Markus Tingart

    (2021)
    68 Citations
  • Clinical development on the frontier: gene therapy for duchenne muscular dystrophy.

    Damon R. Asher;Khampaseuth Thapa;Sachi D. Dharia;Navid Khan

    (2020)
    63 Citations
  • Clinical and histopathological characterization of eczematous eruptions occurring in course of anti IL-17 treatment: a case series and review of the literature.

    G. Caldarola;F. Pirro;A. Di Stefani;M. Talamonti

    (2020)
    61 Citations

Related Online Degrees & Career Pathways

For those interested in the medical field but seeking alternatives or complementary careers to traditional medicine, there are several online degree options worth exploring. An accelerated kinesiology degree online offers a focused path into understanding human movement and physical rehabilitation, which can be crucial for sports therapy and physical fitness careers.

Nurses looking to advance their careers can benefit from specialized certificates that are available online. The pmhnp online programs provide a faster route to becoming a Psychiatric-Mental Health Nurse Practitioner, addressing growing mental health care needs. Similarly, the shortest online nurse practitioner program offers a time-efficient way for nurses to enhance their qualifications and expand their scope of practice as Family Nurse Practitioners.

Another growing area in healthcare is nutrition, where professionals support wellness through diet management. Those interested can explore online dietetics programs to earn credentials that enable them to guide individuals toward healthier lifestyle choices, an increasingly important aspect of preventive medicine.

Each of these pathways provides flexible, accredited options to upskill without the need to physically attend traditional campuses, making them attractive for working professionals or those balancing other commitments.

Best Scientists Contributing to This Journal